The increased CD8+ and reduced Treg frequencies resulted in a positive shift of the CD8+/Treg ratio, which importantly has also been described for this tumor model in CD96/PD-1 dual knockout mice [40]. The gene discussed is CD8A; the disease is neoplasm.